<DOC>
	<DOC>NCT01166074</DOC>
	<brief_summary>This study is a retrospective chart review of the use of subcutaneous IgG (SCIG) in infants less than two years old.</brief_summary>
	<brief_title>Retrospective Chart Review of Subcutaneous IgG Use in Infants</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Infants who received more than one dose of IgG by the subcutaneous route before the age of two years. Consent of parent/guardian if required by institution/IRB. Infants with protein losing conditions such as lymphangiectasis, nephrosis, S/P cardiothoracic surgery requiring drainage tubes for more than 48 hrs, protein losing enteropathy. Concomitant treatment with plasma, other blood products or IGIV while on SCIG. Lack of consent by parent/guardian (if required by Institution/IRB). Any other condition or treatment which, in the opinion of the local investigator, would interfere with obtaining valid results for that subject.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>